Keros Therapeutics logo
Keros Therapeutics KROS
$ 61.39 2.39%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Keros Therapeutics ROE Ratio 2011-2024 | KROS

Annual ROE Ratio Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-46.05 -37.73 -24.16 -17.33 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-17.33 -46.05 -31.32

Quarterly ROE Ratio Keros Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-46.91 -47.66 -34.91 -44.67 -41.09 -42.5 -33.49 -42.78 -42.31 -36.03 -22.31 -26.91 -22.22 -19.7 -13.25 5.0 27.85 46.63 49.29 49.29 31.04 16.37 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
49.29 -47.66 -13.24